Research into molecular and genetic mechanisms underlying prostate carcinogenesis would be greatly advanced by in vitro models of prostate tumors representing primary tumors. We have successfully established an immortalized human prostate epithelial (HPE) cell culture derived from a primary tumor with telomerase. The actively proliferating early passaged RC-58T cells were transduced through infection with a retrovirus vector expressing the human telomerase catalytic subunit (hTERT). A high level of telomerase was detected in RC-58T/hTERT cells but not RC-58T cells. RC-58T/ hTERT cells are currently growing well at passage 50, whereas RC-58T cells senesced at passage 7. RC-58T/ hTERT cells exhibit transformed morphology. More importantly, these immortalized cells showed anchorageindependent growth as they formed colonies in soft agar and grew above the agar layer. Expression of androgenregulated prostate speci®c gene NKX3.1 and epithelial speci®c cytokeratin 8 (CK8) but not prostate speci®c antigen (PSA) and androgen receptor was detected in RC-58T/hTERT cells. Prostate stem cell antigen (PSCA) and p16 were also expressed in this cell line. RC-58T/hTERT cells showed growth inhibition when exposed to retinoic acid and transforming growth factor (TGF)-b1 known potent inhibitors of prostate epithelial cell growth. A number of chromosome alterations were observed including the loss of chromosomes Y, 3p, 10p, 17p, 18q and the gain of chromosomes 16 and 20. These results demonstrate that this primary tumor-derived HPE cell line retained its transformed phenotypes and should allow studies to elucidate molecular and genetic alterations involved in prostate cancer. This is the ®rst documented case of an established human prostate cancer cell line from a primary tumor of a prostate cancer patient with telomerase. Oncogene (2001) 20, 8036 ± 8041.
Keywords: human prostate cancer cell line; immortalization; telomerase Prostate cancer is the most common male cancer in the US, as well as in the Western world, and the second leading cause of male cancer death in the US (Landis et al., 1999) . The recent progress made in identifying cancer genes and understanding cancer genetics is impressive. However, our understanding of the molecular and genetic mechanisms underlying prostate carcinogenesis remains limited, particularly when compared with other cancers i.e., colon, renal and breast (Dong et al., 1997) . In vitro human cell culture models are critical for de®ning the mechanism of prostate cancer progression and for testing preventive and therapeutic regimens. The generation of immortalized HPE cell culture that will accurately re¯ect the in situ characteristics of malignant prostate epithelium is imperative. In vitro cell culture models of human prostate carcinogenesis have not been widely available or well-characterized until recently (Rhim, 2000) . To date, only four readily available and well-studied longterm human prostate carcinoma cell lines exist (DU145, PC-3, LNCaP, and TSU-Pr1). All four were isolated from metastatic lesions, thus leaving a void in reagents representing long-term human cell lines derived from primary localized adenocarcinoma of the prostate. To study early genetic and molecular lesions of prostate cancer, cell lines derived from primary tumors are urgently needed. However, such cell lines are presently not available. The establishment and maintenance of long-term HPE cell lines from primary tumors have been unsuccessful in the absence of in vitro immortalization. Successful generation of immortal malignant prostate epithelial cell cultures from primary tumor specimens by human papilloma virus (HPV) or simian papovavirus 40 (SV40) has been described (Weijerman et al., 1994; Bright et al., 1997; Iype et al., 1998) . These models are of limited value because the immortalized cells frequently contain viral oncogenic DNA and accompany major cytogenic alterations and growth degradation.
Telomerase is an enzyme responsible for replicating telomeres and is composed of an RNA subunit containing an integral catalytic subunit, hTERT (human telomerase reverse transcriptase) (Greider, 1999) . Telomerase is expressed low in most normal tissues in vivo but is known to become activated during tumorigenesis including prostate carcinogenesis (Sommerfeld et al., 1996) . Recent ®ndings have directly implicated telomerase in the escape from cellular senescence (Greider, 1999) . Indeed, transfection of hTERT into selective human cell types (®broblasts, retinal pigment epithelial, mammary epithelial and endothelial cells) (Greider, 1999; Morales et al., 1999; Jiang et al., 1999; Kiyono et al., 1998; Yang et al., 1999; Ratsch et al., 2001) can itself induce immortalization. Interestingly, telomerase expression in human somatic cells does not induce any change associated with a transformed phenotype or an altered genetic phenotype (Morales et al., 1999; Jiang et al., 1999) . Primary cells transduced with the gene that delays replicative senescence will show increased growth potential without converting transformation or showing karyological artifacts, thus making them ideal in vitro model for the study of prostate carcinogenesis. Our goal is to generate new continuously proliferating HPE cell lines from primary prostate tumors of prostate cancer patients by using telomerase.
To determine whether human prostate cancer cells will be immortalized by the expression of hTERT, we introduced a retrovirus construct expressing hTERT into early-passage (passage 6) RC-58T cells derived from a radical prostatectomy specimen of a 52-year-old Caucasian patient through overnight infection in the presence of polybrene (10 mg/ml). Non-infected cells could not be propagated serially beyond six subcultures. In contrast, the hTERT-infected RC-58T cells have an apparently unlimited lifespan and have been successfully subcultivated for more than 50 passages over the course of 1 year with no evidence of decreased proliferation capacity. The RC-58T/hTERT cells had the typical transformed morphology (Figure 1 ). The cells grew as adherent cells and were more piled-up on each other in some areas.
To con®rm that the immortalized RC-58T/hTERT cells do contain the transduced hTERT, the telomerase repeat ampli®cation protocol (TRAP) (Kim et al., 1994) was carried out. A high level of telomerase activity was detected in RC-58T/hTERT cells but not in the untransduced RC-58T cells (passage 3) ( Figure  2) .
RNA samples from RC-58T, RC-58T/hTERT and 267B1 cells were analysed to determine the expression of speci®c markers by reverse transcriptase-polymerase chain reaction (RT ± PCR) (Xu et al., 2000) . The 267B1 cells were used as a positive control. RC-58T/hTERT cells (passage 15) expressed an androgen-regulated prostate speci®c homeobox gene NKX3.1, an epithelial cell speci®c cytokeratin 8, and GAPDH, but did not express PSA and androgen receptor. PSCA and p16 were also expressed in this cell line (Figure 3) . However, the untransduced RC-58T cells (passage 3) expressed not only NKX3.1, cytokeratin 8, PSCA, GAPDH, but also PSA and androgen receptor ( Table  1) .
The cell line was further analysed for growth properties, such as the size and the growth of cell aggregates above the agar (Steuer et al., 1977) and soft agar colony-forming ability. The RC-58T/hTERT cells formed colonies in soft agar medium and large cell aggregates (Figure 4) . The cell aggregates also grew above the agar (Figure 4) .
To determine tumorigenicity in vivo for the RC-58T/ hTERT cell line (passage 15), 1610 7 cells were injected subcutaneously into the mid-dorsal interscapular region of SCID mice. No measurable tumors were observed after 5 months of observation (Table 1 ). The examination of tumorigenicity of the high-passaged RC-58T/hTERT cells as well as its soft agar-derived cell lines is currently in progress.
The cell line was analysed for its ability to respond to growth inhibitory factors known to regulate prostate cell growth. RC-58T/hTERT cells showed growth inhibition when exposed to TGF-b1 and RA, known potent inhibitors of prostate epithelial growth (Peehl et al., 1989) . RA showed a dose-dependent inhibition of growth to 50% of control at the concentration of 10 ng/ml. TGF-b1 also showed a dose-dependent inhibition of growth ( Figure 5 ).
Cytogenetic characteristics of the RC-58T/hTERT cell line were examined (Table 2 ). According to GTGbanding (Hukku et al., 2000) , the RC-58T/hTERT cell line is hypotetraploid human male (XX/XXY), with . Almost all the chromosomes are involved in some kind of change, and the cell line is highly transformed. Looking critically at each karyotype for loss or gain of normal chromosomes and marker formation, there is prominent involvement of chromosomes 2, 3, 4, 10, 11, 13, 14, 15, 17, 18 and 21 in marker formation. The changes observed in individual chromosomes are prominent loss of 2q344qter (M1), 3p104pter (M2), 4q344qter (M3), 10p124pter (M4), 11p144pter (M12A), 14q114pter (M8), 17p104pter (M5), 18q214qter (M11) ( Figure  6 ). There is also some loss of chromosome copy of 6, 8, 13, 19, 22, and minimum region of 7q314qter (M7), 9p104pter (M15) and 12p (M14), and gain of chromosomes 16 and 20.
The present study appears to represent the ®rst documented case of the telomerase-immortalized human prostate cancer cell line established from a primary tumor of a patient with prostate cancer. The immortalized RC-58T/hTERT cells show a transformed morphology and are grown in serum-free medium. The cells formed colonies in soft agar and large cell aggregates and grew above the agar, the known neoplastic phenotypes. They expressed cytokeratin 8, NKX3.1, PSCA, and p16, but did not express Figure 2 Telomerase activity in extracts from cultured RC-58T/ hTERT cells. 267B1 is an immortalized human prostate epithelial cell line that has been shown to have telomerase activity (Burger et al., 1998) . Cells were analysed for telomerase by TRAP assay as described (Kim et al., 1994) . Figure 3 Analysis of RT ± PCR products generated from the RC-58T/hTERT cell line. 267B1 is an immortalized human prostate epithelial cell line that is already known to express a variety of genes, and is therefore used as a positive control. Each cell line was also evaluated without reverse transcriptase activation which resulted in an internal control. This ®gure shows the representative data through quadruple experiments AR and PSA. They showed growth inhibition when exposed to RA and TGF-b1. The cell line was hypotetraploid and showed a number of chromosome alterations including the loss of chromosomes Y, 2q, 3p, 4q, 10p, 11p, 14q, 17p, 18q and the gain of chromosomes 16 and 20. Among the chromosomes involved in prostate cancer and reported in the literature, in the present study there is observed prominent loss of chromosomes Y (Alers et al., 2000; Brothman et al., 1999) , 3p (Dahiya et al., 1997) , 10p (Ittmann, 1998) , 17p (Sauter et al., 1998) and 18q (Brothman et al., 1999; Sauter et al., 1998) , some loss of 7q (Alers et al., 2000; Brothman et al., 1999; Sauter et al., 1998) and 9p (Perinchery et al., 1999) . Involvement of 1p36 as previously reported (see marker M13) is also observed (Gibbs et al., 1999) . We have previously reported involvement of chromosomes 2q and 4q in the progression of prostate cancer cells (Hukku et al., 2000) and recently observed involvement of only 4q in another primary tumor-derived immortalized cell line (unpublished). Similar loss of 2q and 4q was observed by Alers et al. (2000) in 18% of the cases by comparative genomic hybridization. In our published study (Hukku et al., 2000) , chromosome 8q234qter was translocated with chromosomes 2 and 4, and c-myc was involved in translocation. In the present study, that does not appear to be the case. There are a number of changes involving addition of extra material: 1p+ (M13), 11p+ (M12A), 13p+ (M9), t(14q;?) (M8), t(17q;?) (M5) and 21p+ (M10), but there is no clear-cut observation of ampli®cation of chromosome 8q. Looking at the GTG-banding, there does not appear to be 8q involvement, but we have not yet done any con®rmation with¯uorescent in situ hybridization (FISH) study.
We have previously developed reliable methods for generating and characterizing prostate cancer cell lines derived from primary tumors using HPV-16 E6 and E7 genes (Bright et al., 1997) . These models are not ideal because the immortalizing cells frequently contain viral oncogenic DNA and accompany major cytogenic alterations and growth deregulations. The immortalizing agent may introduce many genetic and epigenetic artifacts into these cells, making it dicult to investigate speci®c alterations unique to the tumors. HPV infection does not appear to be related to prostate cancer development even though it is present in many prostate specimens (McNicol and Dodd, 1990; Anwar et al., 1992; Serth et al., 1999) . The question of whether oncogenic HPV is involved in the pathogenesis of prostate cancer has been a subject of great controversy. As described above, we have succeeded in immortalization by the introduction of telomerase Table 2 Cytogenetic characteristics of RC-58T/hTERT cell line into primary human prostate epithelial cells derived from a prostate cancer patient. As shown by other human cells (Greider, 1999; Morales et al., 1999; Jiang et al., 1999; Kiyono et al., 1998; Yang et al., 1999; Ratsch et al., 2001) , we anticipated that the hTERTimmortalized cell will maintain its phenotypic and genotypic characteristics of its primary cells. It has been reported that the telomerase expression in human somatic cells did not induce changes associated with a transformed phenotype and additional genetic changes (Morales et al., 1999; Jiang et al., 1999) . Conceptually, the successful establishment of spontaneous immortalized human prostate cancer cell lines derived from prostate cancer patients would be ideal and a major breakthrough in prostate cancer research. However, the generation of such cell lines is an extremely rare event and to date has not been reported.
The results obtained have demonstrated that this primary prostate tumor-derived HPE cell line retained its transformed phenotypes. The well-characterized human cancer cell line derived from primary tumor of a prostate cancer patient described here will be useful for identi®cation and characterization of prostate cancer genes. The novel in vitro model will also provide the means for testing new modalities for both prevention and progression of prostate cancer, as well as the methods for testing both chemoprevention and chemotherapeutic agents.
Note added in proof As described above, RC-58T/hTERT cells (passage 15) expressed cytokeratin 8, NKX3.1, PSCA and p16, but did not express AR and PSA. However, we have recently found that some clonal lines of RC-58T/hTERT cells expressed not only cytokeratin 8, NKX3.1, PSCA, and p16, but also expressed AR and PSA.
